Plexxikon Inc. v. Novartis Pharmaceuticals Corporation

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 PLEXXIKON INC., Case No. 17-cv-04405-HSG

8 Plaintiff, ORDER DENYING MOTION TO

EXCLUDE CERTAIN OPINIONS AND

9 v. TESTIMONY OF DEFENDANT'S

TECHNICAL EXPERTS

10 NOVARTIS PHARMACEUTICALS CORPORATION, Re: Dkt. No. 165 11 Defendant. 12 13 Pending before the Court is Plaintiff Plexxikon Inc.’s motion to exclude certain opinions 14 and testimony of Defendant Novartis Pharmaceuticals Corporation’s technical experts. Dkt. No. 15 165. The Court heard argument on this motion on November 1, 2019. See Dkt. No. 341. As 16 detailed below, the Court DENIES the motion. 17 I. BACKGROUND 18 Plaintiff challenges portions of the expert reports and the anticipated testimony of three of 19 Defendant’s technical experts: Dr. Phil S. Baran; Dr. Swaminathan Natarajan; and Dr. Andrew 20 Jennings. Dkt. No. 165. Plaintiff does not appear to question the credentials of the three experts, 21 but instead contends that they have applied incorrect legal…